Peptide Synthesis Market Current and Future Trends, Leading Players, Industry Segments and Regional Forecast by 2022-2032 | Says FMI Analyst
As per the peptide synthesis market survey by Future Market Insights (FMI), the peptide synthesis market is forecasted to register a CAGR of 7% from 2022 to 2032.
Growth in this market is majorly influenced by the
prevalence of a wide range of applications of peptides in the treatment of
various lifestyle disorders, such as cancers, diabetes, and obesity.
Owing to their large chemical space, high biological
activity, and low toxicity, peptide synthesis in pharmaceutical
manufacturing is increasingly being considered as active in drug
development and in turn is expected to flourish the peptide synthesis market
and rise the adoption of peptide synthesis process.
Peptides generate billions of dollars in revenue in
oncology, diabetes, and obesity, among other therapeutic areas.
Ask for the Report
Sample: https://www.futuremarketinsights.com/reports/sample/rep-gb-14257
The COVID-19 pandemic has prompted major pharmaceutical and
biotechnology firms, as well as peptide synthesis firms, to invest in
therapeutic and peptide-based vaccine research and development.
Also, peptide synthesis has risen to the forefront due to increased demand
for peptide synthesis drugs and vaccines.
The peptide-based approach marks a pivotal point
as peptides have demonstrated unique selectivity and specificity toward
specific targets.
CoVac-1 is a peptide-based vaccine candidate that combines
SARS-CoV-2 T-cell epitopes derived from various viral proteins with the
Toll-like receptor 1/2 agonist XS15 emulsified in Montanide ISA51 VG, with the
goal of inducing profound SARS-CoV-2 T-cell immunity to combat COVID-19.
Such advancements have resulted in an emerging trend
in peptide synthesis market, thereby surged the demand for reagents
and equipment used in the production of peptides.
The lack of a unified set of regulations has made obtaining
approvals for therapeutic peptides toilsome, limiting their application areas.
This is regarded as a major impediment to the growth of the global peptide
synthesis market.
Considering all of the above-mentioned factors, the peptide
synthesis market size is expected to be around US$ 720 Mn by
2026.
Key Takeaways
- Peptide
synthesis market future trends suggests that the market is
anticipated to be dominated by the reagents segment.
- The
historical performance of the peptide synthesis market was modest with the
valuation of US$ 514 in 2021.
- The
APAC peptide synthesis market is expected to continue to grow at the
fastest rate, owing to increased investments by pharmaceutical as well as
increased R&D activities in the region's countries.
- Based
on end use, pharmaceutical and biotechnology companies are expected to
hold a significant market share due to the increasing use of peptides
for therapeutic drug development.
- By
technology, the segment of solid-phase peptide synthesis is
expected to advance at faster pace due to ease of peptide
purification.
“High prevalence of chronic diseases, and increased
investments in the development of structure-based drug designs can all be
attributed to North America's large peptide synthesis market share as
the rising number of cancer cases is expected to drive peptide
synthesis market growth and as per the World Health Organization
article, 18.1 million new cancer cases are reported worldwide each year. Add to
that the demand for immunity-boosting drugs in the times of COVID-19 and the
market potential seems conducive.” says an FMI analyst.
Competitive Landscape:
The global peptide synthesis market is dominated by the
following companies:
CEM Corporation, Merck KGaA, PuroSynth, Syngene, Lonza,
GenScript Biotech Corporation, Novo Nordisk A/S, Bachem Holding AG,
ThermoFisher Scientific Inc., Gyros Protein Technologies, Creative Diagnostics,
Biotage AB and AAPPTec among others.
Some peptide synthesis companies are
expanding their market position through various strategies such as
acquisitions, mergers, and research collaborations, whereas others are
maintaining their market share by introducing new products.
- CEM
Corporation unveiled Liberty PRO, the world's first large-scale automated
microwave peptide synthesiser. The system can synthesise 1 kg of crude
peptide per batch in reaction vessels ranging in size from 1 to 15 litres,
with unrivalled purity, speed, and waste reduction fueling market revenue
share.
- Pfizer,
Inc. and Imcyse SA have announced a research collaboration to develop
Imotope, a specifically modified peptide. This peptide was developed to
treat rheumatoid arthritis and the same augurs well for the future
of peptide development.
About the Healthcare Division at Future Market Insights
Future Market Insights facilitates corporates, government,
investors, and associated audiences in the healthcare sector to
identify and accentuate vital aspects applicable to product strategy,
regulatory landscape, technology evolution, and other crucial issues to achieve
sustainable success. Our unique approach to gathering market intelligence
equips you in devising innovation-driven trajectories for your business. Know
more about our sector coverage here
About Future Market Insights (FMI)
Future Market Insights (FMI) is a leading provider of market
intelligence and consulting services, serving clients in over 150 countries.
FMI is headquartered in Dubai, and has delivery centers in the UK, U.S. and
India. FMI's latest market research reports and industry analysis
help businesses navigate challenges and make critical decisions with confidence
and clarity amidst breakneck competition. Our customized and syndicated
market research reports deliver actionable insights that drive sustainable
growth. A team of expert-led analysts at FMI continuously tracks emerging
trends and events in a broad range of industries to ensure that our clients
prepare for the evolving needs of their consumers.
Contact Us:
Future Market Insights
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
Comments
Post a Comment